2652.HK
CF PHARMTECH
HK$39.00
+1.09%
2026-02-27
About CF PHARMTECH
CF PharmTech, Inc. engages in research and development, production, and sale of respiratory drugs and other related medical products in China. It offers Shufeimin, an azelastine hydrochloride and fluticasone propionate nasal spray; ChangQi, a budesonide inhalation suspension solution; ChangShu, a salbutamol sulfate inhalation solution; and piezoelectric mesh nebulizer, electric nasal cleaner, BFS hypertonic and physiological seawater nasal cleansing fluid products under the ChangShu name. The company also develops products for the treatment of respiratory diseases, including allergic rhinitis, asthma, chronic obstructive pulmonary, respiratory infection, pulmonary fibrosis, pulmonary hypertension, and other respiratory diseases. In addition, it develops therapeutic products for respiratory and other diseases, such as inhalation spray and aerosol, dry powder inhaler, nebulization, nasal spray products, as well as liposomes. Further, the company provides CDMO/CMO technical services. CF PharmTech, Inc. was formerly known as Suzhou CF PharmTech Co., Ltd. CF PharmTech, Inc. was founded in 2007 and is based in Suzhou, China.
Key Fundamentals
P/E Ratio
2222.00
EPS (TTM)
HK$0.01
ROE
0.2%
Revenue Growth (YoY)
-2.7%
Profit Margin
0.6%
Debt/Equity
8.22
Price/Book
5.40
Market Cap
HK$8.16B
Avg Volume (10D)
676K
Recent Breakout Signals
No recent breakout signals detected for 2652.HK.
Recent Price Range (60 Days)
60D High
HK$39.50
60D Low
HK$30.12
Avg Volume
207K
Latest Close
HK$39.00
Get breakout alerts for 2652.HK
Sign up for Breakout Scanner to receive daily notifications when 2652.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
CF PHARMTECH (2652.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 2652.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 2652.HK operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.